Drug Week
Susan Hasty, Publisher
Table of Contents . . . March 8th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
AIDS and HIV Therapy - Hydroxyurea effective against infected dendritic cells
Patient Safety - NCQA convenes human research protection advisory council
AIDS and HIV Therapy - Antiretroviral therapy lowers coagulation-related activity
AIDS and HIV Therapy - Neomycin B-arganine conjugate shows promise
Drug Development - New alliance has basis in gene discovery collaboration
Ophthalmology - Disinfecting solution proven effective against serious eye infections
Tuberculosis Therapy - Isoniazid safe for lupus patients on steroid therapy
AIDS Therapies - New one-tablet, once-daily formulation of Sustiva approved
AIDS Vaccines - GlaxoSmithKline Biologicals announces start of human trial of novel HIV vaccine
Antiangiogenesis - Drug target discovery alliance is expanded
Clinical Trials - Clinical, pharmacologic research acquisition complete
Conference Announcement - Metabolic Diseases Drug Discovery and Development summit May 6-7
Conference Announcement - New pharma chemistry in drug discovery conference: April 4-5, 2002
Drug Development - British biotech firm achieves high growth in United States
Drug Development - Ciphergen develops enhanced ProteinChip Arrays for drug discovery applications
Drug Development - Comprehensive platform being developed for chemoinformatics
Drug Development - Deltagen announces first target from its research pipeline
Finance - January is disappointing for biotech stocks
Gastrointestinal Motility - Company to reinitiate clinical trials of investigational agent
Information Technology - Unique database of known drugs in production
Medicare - Study: Generic drugs could offer billions in savings over next decade
Migraine - Pozen announces favorable preliminary results for MT 100, commences final MT 300 trial
Obesity - Topiramate development extended to simplify dosing, improve tolerability
Ovarian Cancer - AltaRex announces additional phase IIb results for OvaRex
Pharmaceutics - Strategic alliances: Rigorous selection creates partners in profit
Regulatory Issues - FDA approves 16 new biotech products, 8 new indications in 2001
Tuberculosis - Agreement reached on development of nitroimidazole-related compound for TB treatment
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
